Tenet Healthcare (NYSE:THC) Upgraded by Wall Street Zen to "Strong-Buy" Rating

Key Points

• Wall Street Zen upgraded Tenet Healthcare to “Strong Buy” from “Buy,” while analysts’ consensus remains “Buy” with an average price target of $273.00.
• Tenet reported strong quarterly results, earning $6.12 per share versus the $4.26 consensus estimate and generating $6.04 billion in revenue, up 6.8% year over year.
• The stock opened at $280.60, near its 12-month high of $280.89. Despite heavy institutional ownership at 95.44%, insiders sold 41,375 shares worth approximately $9.8 million over the past three months.

Tenet Healthcare (NYSE:THC - Get Free Report) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Sunday.

Several other equities analysts have also recently issued reports on the stock. Stephens reaffirmed an "overweight" rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Piper Sandler set a $308.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Zacks Research raised Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. Cantor Fitzgerald restated an "overweight" rating on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Raymond James Financial reiterated an "outperform" rating and issued a $285.00 price target on shares of Tenet Healthcare in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $273.00.

Tenet Healthcare Stock Performance

NYSE THC opened at $280.60 on Friday. Tenet Healthcare has a 12-month low of $157.58 and a 12-month high of $280.89. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The business's 50 day moving average is $220.53 and its two-hundred day moving average is $206.80. The stock has a market capitalization of $22.59 billion, a price-to-earnings ratio of 10.82, a PEG ratio of 1.07 and a beta of 1.23.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion during the quarter, compared to analysts' expectations of $5.43 billion. During the same quarter last year, the business posted $4.02 earnings per share. The company's quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Research analysts expect that Tenet Healthcare will post 20.97 EPS for the current year.

Insider Buying and Selling

In related news, Director Tammy Romo sold 2,500 shares of the company's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $260.83, for a total value of $652,075.00. Following the completion of the sale, the director directly owned 28,284 shares in the company, valued at approximately $7,377,315.72. This represents a 8.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Roy Blunt sold 600 shares of the firm's stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total value of $157,608.00. Following the transaction, the director owned 4,589 shares in the company, valued at approximately $1,205,438.52. This trade represents a 11.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 41,375 shares of company stock valued at $9,793,347. 0.97% of the stock is owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. NewEdge Advisors LLC boosted its holdings in shares of Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company's stock worth $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp lifted its position in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company's stock worth $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare during the second quarter valued at about $290,000. Quantbot Technologies LP acquired a new stake in shares of Tenet Healthcare in the second quarter valued at about $65,000. Finally, Amundi increased its stake in shares of Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company's stock worth $4,652,000 after purchasing an additional 26,383 shares during the period. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source